跳轉至內容
Merck
全部照片(1)

重要文件

880420P

Avanti

18:0 PEG350 PE

Avanti Research - A Croda Brand 880420P, powder

同義詞:

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] (ammonium salt)

登入查看組織和合約定價


About This Item

CAS號碼:
分類程式碼代碼:
51191904
NACRES:
NA.25

形狀

powder

包裝

pkg of 1 × 25 mg (880420P-25mg)
pkg of 1 × 500 mg (880420P-500mg)

製造商/商標名

Avanti Research - A Croda Brand 880420P

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

[H][C@@](COP([O-])(OCCNC(OCCOCCOCCOCCOCCOCCOCCOC)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.[NH4+]

應用

18:0 PEG350 PE is suitable for liposome modification.

包裝

30 mL Amber Wide Mouth Bottle with Screw Cap (880420P-500mg)
5 mL Clear Glass Sealed Ampule (880420P-25mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo
Sieber S, et al.
Nanomedicine: Nanotechnology, Biology, and Medicine, 17, 82-93 (2019)
Sandro Sieber et al.
Nanomedicine : nanotechnology, biology, and medicine, 17, 82-93 (2019-01-20)
Macrophage recognition of nanoparticles is highly influenced by particle size and surface modification. Due to the lack of appropriate in vivo screening models, it is still challenging and time-consuming to characterize and optimize nanomedicines regarding this undesired clearance mechanism. Therefore
Liming Deng et al.
Biomaterials science, 8(3), 858-870 (2019-12-07)
Hypoxic resistance, photosensitizer toxicity, and target deficiency are major challenges strongly inhibiting the efficacy of clinical photodynamic therapy (PDT) in tumor treatment. To overcome these challenges, we synthesized IR780 and catalase co-loaded liposomes to form a tumor-targeted bio-nanoreactor (LIP-IR-CAT). The

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務